Juliet Spencer, PhD, University of San Francisco, CA
The purpose of this study was to evaluate cmIL-10 levels in healthy women and women with breast cancer. The research team was investigating whether this test can be used to identify patients who are most likely to benefit from anti-viral drug treatments or monitor how their cancer is responding to treatment. The researchers turned to the Army of Women (AOW) to enroll up to 150 volunteers in the San Francisco, California, area. The Call to Action for this study was sent to AOW members on September 16, 2015. The researchers closed enrollment on August 22, 2016, after the AOW provided them with 146 women who were interested in enrolling in the study.
A Conversation with Dr. Juliet Spencer